Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD8848 in allergic asthma
NCT00999466Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic asthma comparing AZD8848 with Placebo (2 arms). Primary endpoint: FEV1, Late Asthmatic Response (LAR). Started Oct 2009; status: completed.
02
Drugs
azd-8848
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00999466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999466.